arrow
T

Takashi Yamamura

National Center of Neurology and Psychiatry
H指数:75
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study (vol 12, e200450, 2025)

Bennett JL,Fujihara K,Saiz A,Traboulsee AL,Greenberg BM,Weinshenker BG,等。来自SAkuraMoon开放标签扩展研究的视神经脊髓炎谱系障碍患者中萨他利珠单抗的长期疗效与安全性。Neurology® Neuroimmunology Neuroinflamm.(2025)12:e200450。doi:10.1212/NXI.0000000000200494。

2025-11-010
PRE
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance

日本视神经脊髓炎谱系障碍患者中萨他利珠单抗的安全性及有效性:一项为期30个月的市场后监测中期分析

2025-09-260
OAAI
Analysis of infection rates in neuromyelitis optica spectrum disorder: Comparing satralizumab treatment in SAkuraMoon, post-marketing, and US-based health claims data

视神经脊髓炎谱系障碍感染率分析:比较SAkuraMoon研究、上市后研究和基于美国医疗索赔数据的satralizumab治疗。

2025-07-010
PRE
Tyzzerella nexilis strains enriched in mobile genetic elements are involved in progressive multiple sclerosis (vol 43, 114785, 2024)

Tyzzerella nexilis菌株中富集的移动遗传元件参与多发性硬化进展(卷43,114785,2024)

2025-01-010
OA
Eomesodermin-expressing CD4 Th cells and association with multiple sclerosis progression and brain atrophy

Eomesodermin表达CD4 Th细胞及其与多发性硬化进展和脑萎缩的关联

2025-01-010
PRE
Resident Memory-like CD8+ T Cells Are Involved in Chronic Inflammatory and Neurodegenerative Diseases in the CNS

常驻记忆样CD8 T细胞参与中枢神经系统的慢性炎症和神经退行性疾病

2024-01-015
OAAI